122 related articles for article (PubMed ID: 800315)
1. Clinical and hemodynamic effects of high doses of slow release furosemide in arterial hypertension. A double-blind cross-over study with cyclopenthiazide.
Krogsgaard AR; Trap-Jensen J; Hartling O; Svendsen TL
Acta Med Scand Suppl; 1976; 602():110-3. PubMed ID: 800315
[No Abstract] [Full Text] [Related]
2. "24-hour blood pressure control" with sustained release oxprenolol 160mg plus cyclopenthiazide 0.25mg (Trasidrex) in general practice.
Forrest WA; Bridgman KM; Ebbutt AF
Br J Clin Pract; 1983; 37(11-12):385-8. PubMed ID: 6367794
[No Abstract] [Full Text] [Related]
3. [Evaluation of the hypotensive effect of slow-release Trasicor].
Cybulska I; Brym E
Kardiol Pol; 1982; 25(4):329-35. PubMed ID: 6755030
[No Abstract] [Full Text] [Related]
4. The treatment of hypertension in older patients: a comparative study between a diuretic, a beta-receptor antagonist and their fixed combination.
Forrest WA
Practitioner; 1982 Apr; 226(1366):777-8. PubMed ID: 7045851
[No Abstract] [Full Text] [Related]
5. A comparative study of frusemide-amiloride and cyclopenthiazide-potassium chloride in the treatment of congestive cardiac failure in general practice.
Crawford RJ; Allman S; Gibson W; Kitchen S; Richards HH
J Int Med Res; 1988; 16(2):143-9. PubMed ID: 3378660
[TBL] [Abstract][Full Text] [Related]
6. An open, parallel group study comparing a frusemide/amiloride diuretic and a diuretic containing cyclopenthiazide with sustained release potassium in the treatment of congestive cardiac failure--a multicentre general practice study.
Allman S; Norris RJ
J Int Med Res; 1990; 18 Suppl 2():17B-23B. PubMed ID: 2193840
[TBL] [Abstract][Full Text] [Related]
7. Lipids and lipoprotein fractions after cyclopenthiazide and oxprenolol: a double-blind crossover study.
Crisp AJ; Kennedy PG; Hoffbrand BI; Ebbutt AF; Carruthers M
Curr Med Res Opin; 1980; 7(2):101-3. PubMed ID: 7002477
[TBL] [Abstract][Full Text] [Related]
8. Use of a sustained-release formulation of oxprenolol and cyclopenthiazide ('Trasidrex') in the management of hypertension: a general practice study.
Forrest WA
Curr Med Res Opin; 1980; 6(8):559-63. PubMed ID: 7389387
[TBL] [Abstract][Full Text] [Related]
9. [2 antihypertensive therapeutic regimes compared in a controlled clinical trial in general practice. Cyclopenthiazide + KC1/methyldopa versus oxprenolol/hydralazine].
Gyntelberg F; Jacobsen K; Martlev A; Backer P
Ugeskr Laeger; 1977 Mar; 139(11):641-6. PubMed ID: 320734
[No Abstract] [Full Text] [Related]
10. Experience with Trasidrex in the management of inadequately controlled hypertension in general practice.
Forrest WA
Br J Clin Pract; 1980 May; 34(5):140-3. PubMed ID: 6893270
[No Abstract] [Full Text] [Related]
11. A study comparing indapamide with cyclopenthiazide in geriatric patients.
Khan AU
Postgrad Med J; 1981; 57 Suppl 2():42-3. PubMed ID: 7033945
[TBL] [Abstract][Full Text] [Related]
12. Low and conventional dose cyclopenthiazide on glucose and lipid metabolism in mild hypertension.
McVeigh GE; Dulie EB; Ravenscroft A; Galloway DB; Johnston GD
Br J Clin Pharmacol; 1989 Apr; 27(4):523-6. PubMed ID: 2655692
[TBL] [Abstract][Full Text] [Related]
13. Efficacy of a combination of diuretic, beta-blocker and vasodilator in the treatment of hypertension in general practice.
Forrest WA
Br J Clin Pract; 1978 Nov; 32(11):326-32. PubMed ID: 737111
[No Abstract] [Full Text] [Related]
14. The case for low dose diuretics in hypertension: comparison of low and conventional doses of cyclopenthiazide.
McVeigh G; Galloway D; Johnston D
BMJ; 1988 Jul; 297(6641):95-8. PubMed ID: 3044503
[TBL] [Abstract][Full Text] [Related]
15. A comparison of slow Trasicor (oxprenolol 160 mg) and Trasidrex (oxprenolol 160 mg and cyclopenthiazide 0.25 mg) in the treatment of hypertension in general practice.
Elsdon-Dew RW; Holden E
J Int Med Res; 1981; 9(5):315-8. PubMed ID: 7028531
[No Abstract] [Full Text] [Related]
16. The treatment of hypertension in older patients: a double-blind, between-patient study, in previously treated patients comparing a diuretic, a beta-receptor antagonist, and their fixed combination.
Forrest WA
J Int Med Res; 1981; 9(6):490-4. PubMed ID: 7033014
[TBL] [Abstract][Full Text] [Related]
17. Effect of slow oxprenolol and a combination of slow oxprenolol and cyclopenthiazide on plasma lipoproteins.
Ballantyne D; Ballantyne FC; McMurdo
Atherosclerosis; 1981 Jun; 39(3):301-6. PubMed ID: 7259814
[TBL] [Abstract][Full Text] [Related]
18. Long-term treatment with slow-release frusemide compared with thiazide treatment in arterial hypertension.
Jørgensen H; Anderssen N; Silsand T; Peterson LE
J Int Med Res; 1989; 17(6):552-9. PubMed ID: 2628132
[TBL] [Abstract][Full Text] [Related]
19. Xipamide and cyclopenthiazide in essential hypertension--comparative effects on blood pressure and plasma potassium.
MacGregor GA; Banks RA; Markandu ND; Roulston J
Br J Clin Pharmacol; 1982 Jun; 13(6):859-63. PubMed ID: 7046777
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the antihypertensive effects of indapamide and cyclopenthiazide.
James I; Griffith D; Davis J; Wollard M; Waddell G
Postgrad Med J; 1981; 57 Suppl 2():39-41. PubMed ID: 7322959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
